Biosenta Inc.
ZRO
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 100.00 | 100.00 | 200.00 | 200.00 | 300.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00 | 100.00 | 200.00 | 200.00 | 300.00 |
| Cost of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Gross Profit | 100.00 | 0.00 | 100.00 | 100.00 | 200.00 |
| SG&A Expenses | 195.60K | 252.90K | 195.40K | 227.80K | 177.90K |
| Depreciation & Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 500.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 208.90K | 263.60K | 198.10K | 235.70K | 182.70K |
| Operating Income | -208.80K | -263.50K | -197.90K | -235.50K | -182.30K |
| Income Before Tax | -427.40K | -463.60K | -433.60K | -473.70K | -419.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -427.40K | -463.60K | -433.60K | -473.70K | -419.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -427.40K | -463.60K | -433.60K | -473.70K | -419.70K |
| EBIT | -208.80K | -263.50K | -197.90K | -235.50K | -182.30K |
| EBITDA | -208.40K | -263.10K | -197.50K | -235.00K | -181.90K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 32.83M | 33.89M | 33.77M | 32.94M | 32.45M |
| Average Diluted Shares Outstanding | 32.83M | 33.89M | 33.77M | 32.94M | 32.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |